A purple and pink letter v on a white background.
October 6, 2021

How to Advise Your Patients Before Their Aesthetic Treatments

When it comes to patient satisfaction, the journey begins well before your client shows up for their treatment.   Beginning with the consultation, you   have the opportunity to   guide patient expectations, make the right choices for their aesthetic goals, and make sure   they ’ re   getting the most out of their clinic appointments by practicing the proper preparation and aftercare.   Below, we cover the essential steps to follow to prep patients before their treatments   in order to   ensure a positive experience.  

Perfecting the Consultation  

Here ’ s   what you can do to make the most out of your   initial   consultation with each client:    

Listen.   The key to a successful doctor-patient consult is to listen.   They ’ ve   already chosen to come to your clinic, so   there ’ s   no need to dwell on your credentials or past successes beyond a quick introduction. Patients want to feel like they are being listened to, especially since discussing aesthetic concerns can make some people feel vulnerable .      

Identify   the priority concern.   Potential clients will come to you with a variety of aesthetic concerns which may fall into one of the following four major categories:   beautification , transformation, correction, or positive aging. They may have very general or   very specific   ideas of what   they ’ d   like to address. During the consultation,   it ’ s   your task to discern what their needs are and if your services or offerings are a good fit for them. Once you have,   you ’ ll   be   in a position   to discuss more specific   possible   treatments , and   begin to develop a customized aesthetic treatment plan.  

Discuss treatment options.   Once   you ’ ve   assessed the client ’ s needs, inform them about the treatment options that will best address their concerns. There may be more than one, or   a range of invasive vs. non-invasive treatments for them to choose from . Be upfront about procedure outcomes and   do wntime,   and   use plain language. Th ere ’ s n o reason to be covert about the science behind medical aesthetics — your clients will simply google the information for themselves, so it ’ s b est if they receive the correct info from you first.  

Make a plan .   Once you and your client have chosen a treatment, use it as a jumping-off point to create   a customized plan that incorporates both their short-term and long-term aesthetic goals . Having a plan personally tailored to their needs makes patients feel   heard and   does good for your business by creating a reason for them to return.   

Important Points  to  Discuss  with  Patients Pre-Treatment    

Besides getting a basic medical history, here is the key information   you ’ ll   want to discuss with clients before each treatment:    

  • Their g oals and expectations   
  • Their   s un exposure history ,   past   and recent , and whether they have had cause to see a dermatologist  
  • Their h istory of skin conditions   
  • If   they ’ ve   had any   pr evious   fillers   or injectables like   Botox , and   where  
  • Their s kin care routine   including specifics about which products they use  
  • Their m ost recent use of retinol   and when they last had a   chemical peel  
  • What their l ast   aesthetic   treatment   was and its outcome  
  • For hair and body treatments , discuss their goals and expectations and any prior treatments th ey ’ ve h ad  

Managing Patient Expectations Before  A  Treatment  

Asking your patients about their expectations for each treatment is a necessary step on the path to patient satisfaction. When results fall short of expectations; this is where dissatisfaction creeps in. That makes it your responsibility to   manage patient expectations from the start , and this can be done through simple discussion. Ask them how they expect to look and feel after a single treatment, or after several treatments if that is part of their treatment plan, to de termine i f their expectations are reasonable. Then, adjust accordingly by explaining the results that can be achieved. Ab ove all, be f orthcoming about all aspects of the aesthetic treatment your client has chosen to undertake. They should know what to expect in terms of cost, results, re quired d o wntime,   and the experience of having the treatment itself. That way, when everything goes better than planned, they will leave your clinic more than satisfied.  

Discuss Post-Treatment Care  

The best time to discuss aftercare with your patients is   actually before   the treatment itself. Be sure to emphasize the   importance of aftercare   and   especially sun care   for your patients to secure the best results from their treatment. Offering them some post-treatment literature is a good way to ensure they ’ ll be able to follow your advice at home. This can be a brief list of what they should do in the weeks following a procedure, customized for each treatment. Educate them on possible side effects and what to do if these occur, including informing them if you offer an after-hours emergency line.    

We hope that this guide has left you feeling more than prepared to set your patients on their aesthetic journey on the right foot.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.